Since 2005, the U.S. Food and Drug Administration has fielded over 1,000 complaints of potentially serious, sometimes life-threatening problems linked to mesh devices used to treat Pelvic Organ Prolapse (POP) and the related issue of Stress Urinary Incontinence (SUI) in women whose pelvic muscles have weakened.
Pelvic organ prolapse is a condition in which the muscles and tissues around the pelvis that support the bladder, the uterus, and the rectum weaken, allowing these organs to move around or press into the vagina.